Skip to main content

Table 2 Age standardized study population characteristic by subtypes of cases in means (standard deviations) or percents, Cancer of the Prostate Sweden Study

From: Total antioxidant intake and prostate cancer in the Cancer of the Prostate in Sweden (CAPS) study. A case control study

 

Fatal

Advanced

Localized

High grade

Low grade

N

307

499

1020

231

693

FRAP diet (mmol/d)

21.6 (7.9)

22.5 (8.9)

22.2 (8.1)

21.3 (8.0)

22.3 (8.0)

FRAP fruit/vegs (mmol/d)

3.5 (1.9)

3.4 (1.7)

3.5 (1.7)

3.6 (2.0)

3.4 (1.6)

FRAP suppl. (mmol/d)

0.7 (1.2)

0.8 (1.4)

0.9 (1.4)

0.9 (1.3)

0.8 (1.4)

Age

67.0(7.3)

68.6 (7.4)

66.0 (7.1)

68.3 (7.4)

65.4 (7.0)

BMI

26 (3)

26 (3)

26 (3)

26 (3)

26 (4)

Current smokers (%)

14

13

10

12

10

Never smokers (%)

42

39

39

41

38

0–9 years education (%)

53

51

44

48

44

10–12 years education (%)

37

41

40

40

41

13+ yrs education (%)

10

8

17

13

16

Energy kcal/d)

2363 (701)

2334(681)

2270 (630)

2387(655)

2234 (624)

Coffee (cups/day)

3.1 (1.8)

3.2(2.0)

3.1 (1.9)

3.0 (1.9)

3.1 (1.8)

Tea (cups/day)

0.5 (0.8)

0.5 (0.9)

0.7 (1.1)

0.6 (0.8)

0.7 (1.1)

Chocolate (serv./d)

0.2 (0.3)

0.2 (0.3)

0.2 (0.2)

0.2 (0.2)

0.2 (0.2)

Berries (serv./d)

0.2 (0.3)

0.2 (0.2)

0.2 (0.3)

0.2 (0.3)

0.1 (0.2)

Boiled potatoes (serv./d)

0.6(0.4

0.6 (0.4)

0.6 (0.4)

0.6 (0.3)

0.6 (0.4)

Multivitamin use (%)

21

22

21

29

20

Vitamin C suppl. use (%)

12

15

15

16

14

Vitamin E suppl. use (%)

3

3

4

3

5

Calcium (mg/d)

1241(406)

1222 (390)

1188 (363)

1213 (381)

1193 (363)

Zinc (mg/d)

11.5 (1.9)

11.5 (1.9)

11.6 (1.9)

11.6 (1.9)

11.7 (1.8)

PSA at diagnosis

264 (573)

276 (665)

39 (241)

167 (364)

22 (136)

  1. Fatal prostate cancer: Death from prostate cancer through follow up. Advanced prostate cancer: M1, N1, T3 or T4 and death during follow up. Localized prostate cancer: T1 or T2 and N0/M0. High-grade prostate cancer: Gleason sum 8–10. Low-grade prostate cancer: Gleason sum 2–6